Lung transplantation for patients with COVID-19

CS King, H Mannem, J Kukreja, S Aryal, D Tang… - Chest, 2022 - Elsevier
The COVID-19 pandemic has caused acute lung injury in millions of individuals worldwide.
Some patients develop COVID-related acute respiratory distress syndrome (CARDS) and …

[HTML][HTML] Interstitial lung disease in rheumatoid arthritis remains a challenge for clinicians

E Bendstrup, J Møller, S Kronborg-White… - Journal of clinical …, 2019 - mdpi.com
Interstitial lung disease (ILD) is a serious complication of rheumatoid arthritis (RA)
contributing to significantly increased morbidity and mortality. Other respiratory …

Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations

JM Aguado, JT Silva, M Fernández-Ruiz… - Transplantation …, 2018 - Elsevier
Solid organ transplant (SOT) recipients are especially at risk of developing infections by
multidrug resistant (MDR) Gram-negative bacilli (GNB), as they are frequently exposed to …

[HTML][HTML] Extracorporeal life support as a bridge to lung transplantation–experience of a high-volume transplant center

K Hoetzenecker, L Donahoe, JC Yeung, S Azad… - The Journal of thoracic …, 2018 - Elsevier
Objectives Extracorporeal life support (ECLS) is increasingly used to bridge deteriorating
patients awaiting lung transplantation (LTx), however, few systematic descriptions of this …

Targeted therapy of pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018

MM Hoeper, C Apitz, E Grünig, M Halank… - International journal of …, 2018 - Elsevier
In the summer of 2016, delegates from the German Respiratory Society, the German Society
of Cardiology and the German Society of Pediatric Cardiology met in Cologne, Germany, to …

Idiopathic pulmonary fibrosis: current status, recent progress, and emerging targets

YM Liu, K Nepali, JP Liou - Journal of medicinal chemistry, 2017 - ACS Publications
Idiopathic pulmonary fibrosis (IPF), a chronic and progressive fibrosing interstitial
pneumonia, is a fatal lung disease with a median survival time of 3–5 years. Problems in …

Treatment of pulmonary hypertension

MM Hoeper, VV McLaughlin, AM Al Dalaan… - The Lancet …, 2016 - thelancet.com
The most common forms of pulmonary hypertension are pulmonary arterial hypertension,
chronic thromboembolic pulmonary hypertension, and pulmonary hypertension due to left …

[HTML][HTML] Idiopathic pulmonary fibrosis: best practice in monitoring and managing a relentless fibrotic disease

WA Wuyts, M Wijsenbeek, B Bondue, D Bouros… - Respiration, 2020 - karger.com
Idiopathic pulmonary fibrosis (IPF) is a fibrosing interstitial lung disease that is, by definition,
progressive. Progression of IPF is reflected by a decline in lung function, worsening of …

Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: a randomized controlled multicenter clinical trial

P Vitulo, A Stanziola, M Confalonieri… - The Journal of Heart and …, 2017 - Elsevier
Background Pulmonary hypertension (PH) is a well-known independent prognostic factor in
chronic obstructive pulmonary disease (COPD) and a sufficient criterion for lung transplant …

[HTML][HTML] Brazilian guidelines for the diagnosis and treatment of cystic fibrosis

RA Athanazio, LVRF Silva, AA Vergara… - Jornal Brasileiro de …, 2017 - SciELO Brasil
Cystic fibrosis (CF) is an autosomal recessive genetic disorder characterized by dysfunction
of the CFTR gene. It is a multisystem disease that most often affects White individuals. In …